These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 31258693)
1. Overexpression of microRNA-620 facilitates the resistance of triple negative breast cancer cells to gemcitabine treatment by targeting DCTD. Wu C; Zhao A; Tan T; Wang Y; Shen Z Exp Ther Med; 2019 Jul; 18(1):550-558. PubMed ID: 31258693 [TBL] [Abstract][Full Text] [Related]
2. Loss of miR-873 contributes to gemcitabine resistance in triple-negative breast cancer via targeting ZEB1. Wang G; Dong Y; Liu H; Ji N; Cao J; Liu A; Tang X; Ren Y Oncol Lett; 2019 Oct; 18(4):3837-3844. PubMed ID: 31579087 [TBL] [Abstract][Full Text] [Related]
3. miR-497 inhibits proliferation and invasion in triple-negative breast cancer cells via YAP1. Li Y; Hua K; Jin J; Fang L Oncol Lett; 2021 Aug; 22(2):580. PubMed ID: 34122631 [TBL] [Abstract][Full Text] [Related]
4. miR-1207-5p regulates the sensitivity of triple-negative breast cancer cells to Taxol treatment via the suppression of LZTS1 expression. Hou X; Niu Z; Liu L; Guo Q; Li H; Yang X; Zhang X Oncol Lett; 2019 Jan; 17(1):990-998. PubMed ID: 30655858 [TBL] [Abstract][Full Text] [Related]
5. miR-31-5p may enhance the efficacy of chemotherapy with Taxol and cisplatin in TNBC. Shen X; Lei J; Du L Exp Ther Med; 2020 Jan; 19(1):375-383. PubMed ID: 31853314 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A. Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639 [TBL] [Abstract][Full Text] [Related]
7. MiR-153-5p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Paclitaxel by Inducing G2M Phase Arrest. Wang Y; Wu N; Zhang J; Wang H; Men X Onco Targets Ther; 2020; 13():4089-4097. PubMed ID: 32494162 [TBL] [Abstract][Full Text] [Related]
8. miR-205-5p downregulation decreases gemcitabine sensitivity of breast cancer cells via ERp29 upregulation. Ma C; Shi X; Guo W; Feng F; Wang G Exp Ther Med; 2019 Nov; 18(5):3525-3533. PubMed ID: 31602229 [TBL] [Abstract][Full Text] [Related]
9. miR-381 overcomes cisplatin resistance in breast cancer by targeting MDR1. Yi D; Xu L; Wang R; Lu X; Sang J Cell Biol Int; 2019 Jan; 43(1):12-21. PubMed ID: 30444043 [TBL] [Abstract][Full Text] [Related]
10. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner. Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364 [TBL] [Abstract][Full Text] [Related]
11. miR-187-3p increases gemcitabine sensitivity in breast cancer cells by targeting FGF9 expression. Wu Y; Tao L; Liang J; Qiao Y; Liu W; Yu H; Yu X; Liu L Exp Ther Med; 2020 Aug; 20(2):952-960. PubMed ID: 32765654 [TBL] [Abstract][Full Text] [Related]
12. MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction. Chen F; Luo N; Hu Y; Li X; Zhang K Cell Physiol Biochem; 2018; 47(5):2147-2158. PubMed ID: 29975921 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway. Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958 [TBL] [Abstract][Full Text] [Related]
14. MiR-27a modulates radiosensitivity of triple-negative breast cancer (TNBC) cells by targeting CDC27. Ren YQ; Fu F; Han J Med Sci Monit; 2015 May; 21():1297-303. PubMed ID: 25943633 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2. Liu H; Wang G Exp Ther Med; 2021 Sep; 22(3):945. PubMed ID: 34306209 [TBL] [Abstract][Full Text] [Related]
16. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer. Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563 [TBL] [Abstract][Full Text] [Related]
17. Formononetin ameliorates the drug resistance of Taxol resistant triple negative breast cancer by inhibiting autophagy. Li T; Zhang S; Chen F; Hu J; Yuan S; Li C; Wang X; Zhang W; Tang R Am J Transl Res; 2021; 13(2):497-514. PubMed ID: 33594306 [TBL] [Abstract][Full Text] [Related]
18. miRNA-21 promotes proliferation and invasion of triple-negative breast cancer cells through targeting PTEN. Fang H; Xie J; Zhang M; Zhao Z; Wan Y; Yao Y Am J Transl Res; 2017; 9(3):953-961. PubMed ID: 28386324 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-182 targets FOXF2 to promote the development of triple-negative breast cancer. Yu J; Shen W; Gao B; Zhao H; Xu J; Gong B Neoplasma; 2017; 64(2):209-215. PubMed ID: 28043147 [TBL] [Abstract][Full Text] [Related]
20. miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10. Liu F; Zhuang L; Wu R; Li D J BUON; 2019; 24(5):1905-1912. PubMed ID: 31786854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]